Skip to content

MRX changes

Pick any two versions below to diff them.

View the full Oct 11, 2026 version
Price
$71.88 → $71.92(+0.1%)
Next earnings
2026-11-12 → 2026-11-05
Checkpoints
Nov 125, 2026 (estimate): Q3 2026 results with normal volatility. Pending. Watch: Adjusted profit before tax up 10% or more from Q3 2025 with no large client loss passes; a fall in profit as volatility eases fails. Q1 2027 (estimate): Bright Point and Brainchild acquisitions close. Pending. Watch: Both deals close by early 2027 and add client balances without write-downs passes; a delay, a block or a write-down fails. Mar 2027 (estimate): 2026 annual report and internal control opinion. Pending. Watch: Management and the auditor report that both material weaknesses are fixed passes; any remaining weakness or a restatement fails.